NMBA is something that everyone wants to stay away from now. NMBA or N-Methylnitrosobutyric acid is something in the medicines for blood pressure and its appearance in levels which are higher than the levels which are acceptable is said to be a probable carcinogen.
It has come to notice recently that the additional lots of medicines from Torrent Pharmaceuticals Ltd are being recalled by the company according to the Food and Drug Administration of the United States. This recall of lots includes a lot of medicines of blood pressures which have been subject to recall in the last 14 months or so.
In the year 2018 and 2019, it has become evident that the contaminants which are potentially causing cancer are being found in the Blood Pressure medicines repetitively. Similar contaminants have been found in the November of 2018, January of 2019, and March of 2019 and as recently as last year when ranitidine, which is a common medicine for heartburn had impurities found in them which is why the distribution of the medicine is being halted under there are further tests being done.
Experts believe that it is time to look closely at how these medicines are being manufactured, stored and even distributed and how the ones who monitor are being monitor.
Manufacturing of medicines is different from the manufacture of other products in the sense that these medicines may even lead to a threat to life and more serious injury. Although FDA is an organization that is protecting the fraud and contamination in medicines, the scope of FDA right now may not be enough to keep a close watch on the these medicines.